Historical
 
 
  NEWS PEBC  
 

12/04/09
Nobel season at the PEBC
 

10/13/09
Awards and recognitions at PEBC
 

10/13/09
PEBC in "Genes & Development”, “Oncogene”, “Human Molecular Genetics”, “Human Mutation” and “Lancet Neurology"
 
 
 

 

Cancer Epigenetics and Biology Symposium

 

 

The Bellvitge Institute for Biomedical Research (IDIBELL) is a research foundation set up on 16th June 2004 as a separate legal entity resulting from a change in name of the former August Pi i Sunyer (FAPS) Foundation, set up in 1988. IDIBELL has scientific cooperation agreements with the following institutions/centres:

- University of Barcelona (UB) and its science park
- Bellvitge University Hospital (HUB)

- Catalan Institute of Oncology (ICO)

- Institute for Imaging Diagnosis (IDI)

- Transfusion Centre and Tissue Bank (CTBT)

It is a great pleasure to announce the launching in 2008 of a new research program devoted to basic research within IDIBELL, The Cancer Epigenetics and Biology Program (PEBC).

.>> more info

  LAST PUBLICATIONS  
 

Nat Genet - A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. >>

 

Genome Res - The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. >>

 

Hum Mol Genet - The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer >>

 

 
 

 

PEBC Lectures

ICC

 

 
aecc

 

 

 
Generalitat de Catalunya Institut d'Investigacio Biomedica de Bellvitge ICREA Sixth Framework Programme Seventh Framework Programme CNIO Ministerio de Sanidad y Consumo Ministerio de Educación y Ciencia
 
 

© 2008® | PEBC | Todos los derechos reservados |  WEBMAIL  |  INTRANET  |  FTP